MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Progressive ataxia and palatal tremor due to a novel heterozygous GRIN2A mutation

    E. Ardila, G. Kägi, F. Brugger (St. Gallen, Switzerland)

    Objective: Describe the case of a patient with adult-onset progressive ataxia and palatal tremor (PAPT) in association with a novel heterozygous mutation of the GRIN2A…
  • 2022 International Congress

    Utilising multiple murine models to investigate sleep and circadian system dysfunction in PD

    N. Garner, P. Kim, M. Weiergräber, H. Oster, O. Rawashdeh (Brisbane, Australia)

    Objective: We aimed to investigate the impact of alpha-synuclein aggregation and spreading, and nigrostriatal dopaminergic degeneration on sleep homeostasis and circadian function. Background: Sleep dysfunction…
  • 2022 International Congress

    Remote physical activity monitoring programs for Veterans with Parkinson’s disease

    K. Waddell, M. Patel, J. Wilkinson, S. Koganti, S. Wood, J. Morley (Philadelphia, USA)

    Objective: To examine feasibility of a remote physical activity monitoring program and predictors of activity among rural Veterans with PD Background: Patients in rural areas,…
  • 2022 International Congress

    TRPV4 Mutation related Parkinson’s Disease with Scapuloperoneal spinal muscular atrophy

    A. Deenadayalu, P. A, V. Paramanandam (Limerick, Ireland)

    Objective: Scapuloperoneal spinal muscular atrophy (SPSMA) is a rare autosomal dominant disease caused by transient receptor potential cation channel (TRPV4) gene, involving scapular and peroneal…
  • 2022 International Congress

    Functional dystonia on a 46 year-old woman

    F. Rivas, I. Rodríguez, D. Vázquez (San Luis Potosí, Mexico)

    Objective: To report a case of a 46 six years-old woman presenting with functional dystonia Background: Nowadays we use the term dystonia when we are…
  • 2022 International Congress

    Can membrane association of α-synuclein aggregates lead to stress in the astrocytic endoplasmic reticulum?

    A. Raj, I. Datta, R. Banerjee (Bangalore, India)

    Objective: To study the association extracellularly added wildtype-WT and A30P/A53T mutant α-synuclein aggregates with the astrocytic membrane and to evaluate the effect of these peptides…
  • 2022 International Congress

    Sexual dysfunctions in Parkinson’s disease and their influence on partnership – data from the PRISM study

    T. Kinateder, D. Marinho, L. Hatzler, D. Gruber, G. Ebersbach, F. Gandor (Beelitz-Heilstaetten, Germany)

    Objective: To assess the demographics of sexual dysfunction in the PRISM cohort and analyze their influence on patients’ quality of life and their partnership. Background:…
  • 2022 International Congress

    A prospective, controlled study of subthalamic stimulation in Parkinson’s disease: quality of life outcome at the 5-year follow-up

    S. Jost, S. Aloui, A. Rizos, K. Ashkan, J. Evans, A. Sauerbier, J. Petry-Schmelzer, A. Gronostay, G. Fink, M. Barbe, V. Visser-Vandewalle, A. Antonini, M. Silverdale, P. Martinez-Martin, L. Timmermann, K. Ray Chaudhuri, H. Dafsari (Cologne, Germany)

    Objective: To compare the 60-months quality of life (QoL) effects of subthalamic stimulation (STN-DBS) to standard-of-care oral/transdermal medical therapy (MED) in Parkinson's disease (PD). Background:…
  • 2022 International Congress

    Artificial Intelligence based detection of Parkinson’s disease in Magnetic Resonance Imaging brain scans

    M. Courtman, M. Thurston, L. Mcgavin, C. Carroll, L. Sun, E. Ifeachor, S. Mullin (Plymouth, United Kingdom)

    Objective: To use an artificial intelligence (AI) based framework to detect Parkinson's disease (PD) in Magnetic Resonance Imaging (MRI) brain scans. Background: Candidate neuroprotective treatments…
  • 2022 International Congress

    GAIT ANALYSIS IN PARKINSONIAN SUBJECTS WITH PISA SYNDROME SUBJECTED TO TREATMENT WITH BOTULINUM TOXIN

    R. Marvulli, G. Ianieri, A. Zonno, G. Mintrone, G. Farì, L. Rizzo, M. Ranieri, M. Megna (Bari, Italy)

    Objective: The aim was to evaluate the activation characteristics of the muscles involved in patients with Pisa Syndrome with surface electromyography (EMG) during walking after…
  • « Previous Page
  • 1
  • …
  • 132
  • 133
  • 134
  • 135
  • 136
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley